Article

PCSK9 Eligibility Concerns Highlight AJPB Week in Review

Author(s):

Davy James, Managing Editor

Top articles of the week from The American Journal of Pharmacy Benefits.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
3 experts are featured in this series.
3 experts are featured in this series.
1 expert in this video
Related Content
FDA approves REMS modification for sparsentan -- Image credit: wladimir1804 | stock.adobe.com
August 28th 2025

FDA Approves REMS Modification for Sparsentan in IgA Nephropathy

Gillian McGovern, Associate Editor
From Guidelines to Action: Pharmacy’s Role in Hypertension Management
August 28th 2025

From Guidelines to Action: Pharmacy’s Role in Hypertension Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Isolated horizontal image of GLP-1 Semaglutide therapy injection pens - Image credit: Shutterly | stock.adobe.com
August 28th 2025

FDA Approves Generic Version of Liraglutide Injection, a GLP-1 for Weight Loss

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage
August 28th 2025

Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage

Jennifer Griffin, PharmD, MS Luke Halpern, Assistant Editor
Bottle with essential oils, dropper with oil. Fresh oranges. A natural remedy for depression. | Image Credit: MAXSHOT_PL | stock.adobe.com
August 28th 2025

Emerging Evidence Shows Hesperidin's Benefits in Cardiometabolic Health

Danielle Valletti, Assistant Editor
Healthcare cure concept with a hand in blue medical gloves holding Coronavirus, Covid 19 virus, vaccine vial - Image credit: Leigh Prather | stock.adobe.com
August 28th 2025

COVID-19 Vaccination Could Lower Risk of Developing Asthma

Kennedy Ferruggia, Assistant Editor